Positron emission tomography in non-medullary thyroid cancer

被引：3
|
作者：
Shon, Ivan Ho [1 ,4 ,5 ]
Depcynzski, Barbara [1 ,3 ]
Lin, Michael [1 ,4 ,5 ]
Clark, Jonathan R. [2 ]
Wong, Vincent [1 ,3 ]
Lin, Peter [4 ,5 ]
Campbell, Peter [2 ]
机构：
[1] Univ New S Wales, S Western Clin Sch, Sydney, NSW, Australia
[2] Liverpool Hosp, Dept Surg, Liverpool, Merseyside, England
[3] Liverpool Hosp, Diabet & Endocrine Serv, Liverpool, Merseyside, England
[4] Liverpool Hosp, Dept Nucl Med, Liverpool, Merseyside, England
[5] Liverpool Hosp, PET, Liverpool, Merseyside, England
来源：
ANZ JOURNAL OF SURGERY | 2011年 / 81卷 / 03期
关键词：
fluoro-deoxy glucose; positron emission tomography; thyroid neoplasm; thyroid nodule; ELEVATED SERUM THYROGLOBULIN; WHOLE-BODY SCANS; F-18 FDG PET/CT; FOLLOW-UP; RADIOACTIVE IODINE; CARCINOMA PATIENTS; GLUCOSE-TRANSPORT; THYROTROPIN STIMULATION; DIAGNOSTIC-ACCURACY; THERAPEUTIC IMPACT;
D O I：
10.1111/j.1445-2197.2010.05538.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
While iodine scanning is the mainstay of functional imaging in differentiated thyroid cancer, there is now a significant body of literature regarding positron emission tomography with 2-fluoro-2-deoxy glucose in thyroid cancer. This clinical review will examine the evidence supporting the use of 2-fluoro-2-deoxy glucose-positron emission tomography throughout the diagnosis and management of thyroid cancer, and provide suggestions for its clinical use and potential future roles.
引用
收藏
页码：116 / 124
页数：9
相关论文
共 50 条
  • [31] Incidence and Impact of Concomitant non-Medullary Thyroid Cancer to Parathyroid Scan
    Altinyay, M. E.
    Aldakker, M. O.
    Ali, M. A.
    Shehri, S.
    Syed, G. M. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S595 - S595
  • [32] Familial Non-Medullary Thyroid Carcinoma: An Update
    Nose, Vania
    ENDOCRINE PATHOLOGY, 2008, 19 (04) : 226 - 240
  • [33] CARCINOEMBRYONIC ANTIGEN IN NON-MEDULLARY THYROID CANCERS
    PETIT, L
    HANTOUR, Z
    SAVOIE, JC
    PRESSE MEDICALE, 1983, 12 (22): : 1431 - 1431
  • [34] Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum
    Zhou, Jingan
    Singh, Preeti
    Yin, Kanhua
    Wang, Jin
    Bao, Yujia
    Wu, Menghua
    Pathak, Kush
    McKinley, Sophia K.
    Braun, Danielle
    Lubitz, Carrie C.
    Hughes, Kevin S.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6590 - 6600
  • [35] Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
    Miasaki, Fabiola Yukiko
    Fuziwara, Cesar Seigi
    Carvalho, Gisah Amaral de
    Kimura, Edna Teruko
    GENES, 2020, 11 (11) : 1 - 21
  • [36] Does Familial Non-Medullary Thyroid Cancer Adversely Affect Survival?
    Frederic Triponez
    Mariwil Wong
    Cord Sturgeon
    Nadine Caron
    David G. Ginzinger
    Mark R. Segal
    Electron Kebebew
    Quan-Yang Duh
    Orlo H. Clark
    World Journal of Surgery, 2006, 30 : 787 - 793
  • [37] Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer
    Alzahrani, Ali S.
    Alswailem, Meshael
    Alghamdi, Balgees
    Al-Hindi, Hindi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09): : 2539 - 2544
  • [38] Clinical features of pediatric familial non-medullary thyroid cancer (FNMTC)
    M. Capezzone
    F. Maino
    A. Sagnella
    M. Campanile
    C. Dalmiglio
    T. Pilli
    R. Forleo
    M. G. Castagna
    Journal of Endocrinological Investigation, 2021, 44 : 2319 - 2321
  • [39] Does familial non-medullary thyroid cancer adversely affect survival?
    Triponez, F
    Wong, MW
    Sturgeon, C
    Caron, N
    Ginzinger, DG
    Segal, MR
    Kebebew, E
    Duh, QY
    Clark, OH
    WORLD JOURNAL OF SURGERY, 2006, 30 (05) : 787 - 793
  • [40] Clinical features of pediatric familial non-medullary thyroid cancer (FNMTC)
    Capezzone, M.
    Maino, F.
    Sagnella, A.
    Campanile, M.
    Dalmiglio, C.
    Pilli, T.
    Forleo, R.
    Castagna, M. G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (10) : 2319 - 2321
12345